Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy

NCT05169554 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Buruli Ulcer

Interventions

DRUG: Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.
DRUG: Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks.

Sponsor

Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]